SPECIALIZED PRESS February 8, 2021 Not intended for U.S. and UK MediaBayer and Orion expand development program for darolutamide in prostate cancerRead more
SPECIALIZED PRESS February 3, 2021 Not intended for U.S. and UK MediaBayer receives approval for Nubeqa™ in China for the treatment of men with non-metastatic castration-resistant prostate cancer (nmCRPC) Read more
February 2, 2021 Bayer launches The Nutrient Gap Initiative to Expand Access to Vitamins and Minerals for 50 Million People Annually Worldwide by 2030Read more
January 27, 2021 New Leaps by Bayer investment:Ukko secures USD 40 million in Series B funding led by Leaps by Bayer to overcome food allergies and sensitivitiesRead more
SPECIALIZED PRESS January 22, 2021 Not intended for U.S. and UK MediaJapan approves rivaroxaban (XareltoTM) to treat children with venous thromboembolism (VTE) and to prevent recurrenceRead more
SPECIALIZED PRESS January 20, 2021 Not intended for U.S. and UK MediaU.S. FDA approves vericiguat for patients with symptomatic chronic heart failureRead more
